Ocular Pain Associated with Valproic Acid (Depakote)

Clinical Presentation

• Disproportionate ocular symptoms—such as pain that exceeds observable clinical findings—may indicate a neuropathic mechanism of drug‑related ocular discomfort, even when objective signs are minimal. 1, 2

• Burning, aching, sharp pain, photophobia, or wind‑induced sensitivity are characteristic descriptors that suggest a neuropathic component to eye pain in patients receiving valproic acid. 1, 3

Diagnostic Evaluation

• A thorough ocular surface examination should assess for aqueous tear deficiency, tear‑film instability, surface inflammation, and epithelial erosions to identify contributory ocular surface disease. 1, 3

• An anesthetic challenge test can help differentiate pain origins: relief after topical anesthetic implies a peripheral nociceptive or neuropathic source, whereas lack of relief points toward central or non‑ocular causes. 1, 2

Differential Diagnosis

• Dry eye syndrome should be considered, but drug‑related dryness is listed as an exclusion criterion in diagnostic guidelines for ocular pain. 1, 2

• Neuropathic ocular pain may arise from etiologies other than valproic acid and must be evaluated in the differential work‑up. 1, 3

Management Strategies

• When eye pain emerges on valproic acid, clinicians should document symptom quality and severity, perform ocular surface assessment, evaluate metabolic status, and consider an anesthetic challenge before altering therapy. 1, 3